Mitchell, Paul; Annemans, Lieven; White, Richard; … - In: PharmacoEconomics 29 (2011) 2, pp. 107-131
ranibizumab was cost effective for the treatment of wet AMD; most compared ranibizumab with PDT and/or pegaptanib. By contrast … literature analyses, pegaptanib was found to be cost effective versus usual/best supportive care (including PDT) or no treatment … stage of disease and time horizon. PDT was shown to be cost effective versus usual/best supportive care or no treatment in …